Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9B3Y3
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 7 |
GO:0003723 | RNA binding | 4 | 7 |
GO:0005488 | binding | 1 | 7 |
GO:0097159 | organic cyclic compound binding | 2 | 7 |
GO:1901363 | heterocyclic compound binding | 2 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 114 | 118 | PF00656 | 0.510 |
DOC_CKS1_1 | 135 | 140 | PF01111 | 0.477 |
DOC_USP7_MATH_1 | 152 | 156 | PF00917 | 0.495 |
DOC_USP7_MATH_1 | 25 | 29 | PF00917 | 0.425 |
DOC_USP7_MATH_1 | 57 | 61 | PF00917 | 0.522 |
DOC_WW_Pin1_4 | 134 | 139 | PF00397 | 0.475 |
LIG_14-3-3_CanoR_1 | 80 | 87 | PF00244 | 0.625 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.300 |
LIG_BRCT_BRCA1_1 | 11 | 15 | PF00533 | 0.425 |
LIG_FHA_1 | 77 | 83 | PF00498 | 0.372 |
LIG_FHA_2 | 112 | 118 | PF00498 | 0.511 |
LIG_FHA_2 | 45 | 51 | PF00498 | 0.422 |
LIG_LIR_Gen_1 | 154 | 163 | PF02991 | 0.494 |
LIG_LIR_Nem_3 | 154 | 159 | PF02991 | 0.494 |
LIG_LIR_Nem_3 | 161 | 166 | PF02991 | 0.467 |
LIG_LIR_Nem_3 | 21 | 26 | PF02991 | 0.512 |
LIG_MLH1_MIPbox_1 | 11 | 15 | PF16413 | 0.425 |
LIG_Pex14_2 | 11 | 15 | PF04695 | 0.425 |
LIG_Pex14_2 | 156 | 160 | PF04695 | 0.502 |
LIG_SH2_CRK | 26 | 30 | PF00017 | 0.425 |
LIG_TRAF2_1 | 148 | 151 | PF00917 | 0.505 |
LIG_WRPW_2 | 23 | 26 | PF00400 | 0.425 |
MOD_CK1_1 | 128 | 134 | PF00069 | 0.478 |
MOD_CK1_1 | 155 | 161 | PF00069 | 0.497 |
MOD_CK1_1 | 167 | 173 | PF00069 | 0.453 |
MOD_CK1_1 | 60 | 66 | PF00069 | 0.425 |
MOD_CK1_1 | 76 | 82 | PF00069 | 0.342 |
MOD_CK2_1 | 145 | 151 | PF00069 | 0.511 |
MOD_CK2_1 | 44 | 50 | PF00069 | 0.422 |
MOD_GlcNHglycan | 105 | 109 | PF01048 | 0.519 |
MOD_GlcNHglycan | 165 | 169 | PF01048 | 0.469 |
MOD_GlcNHglycan | 82 | 85 | PF01048 | 0.435 |
MOD_GSK3_1 | 100 | 107 | PF00069 | 0.482 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.494 |
MOD_GSK3_1 | 151 | 158 | PF00069 | 0.496 |
MOD_GSK3_1 | 41 | 48 | PF00069 | 0.437 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.502 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.542 |
MOD_N-GLC_1 | 126 | 131 | PF02516 | 0.481 |
MOD_N-GLC_1 | 152 | 157 | PF02516 | 0.494 |
MOD_NEK2_1 | 126 | 131 | PF00069 | 0.481 |
MOD_NEK2_1 | 139 | 144 | PF00069 | 0.477 |
MOD_NEK2_1 | 159 | 164 | PF00069 | 0.454 |
MOD_PIKK_1 | 65 | 71 | PF00454 | 0.406 |
MOD_Plk_1 | 152 | 158 | PF00069 | 0.494 |
MOD_Plk_4 | 155 | 161 | PF00069 | 0.497 |
MOD_Plk_4 | 25 | 31 | PF00069 | 0.425 |
MOD_ProDKin_1 | 134 | 140 | PF00069 | 0.478 |
TRG_DiLeu_BaEn_1 | 115 | 120 | PF01217 | 0.511 |
TRG_DiLeu_BaLyEn_6 | 77 | 82 | PF01217 | 0.382 |
TRG_ENDOCYTIC_2 | 163 | 166 | PF00928 | 0.479 |
TRG_ENDOCYTIC_2 | 26 | 29 | PF00928 | 0.521 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IMA7 | Leishmania donovani | 39% | 100% |
A4HLK8 | Leishmania braziliensis | 42% | 100% |
A4I919 | Leishmania infantum | 41% | 100% |
E9B3Y4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 41% | 100% |
Q4Q440 | Leishmania major | 41% | 100% |